Traws Pharma (TRAW) Change in Receivables (2014 - 2026)
Traws Pharma (TRAW) posted quarterly Change in Receivables of -$2.1 million for Q1 2026, down 1798.2% year-over-year from $124072.7 in Q1 2025, and down 216.86% quarter-over-quarter from $1.8 million in Q4 2025.
Traws Pharma (TRAW) Change in Receivables (2014 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Change in Receivables for 13 consecutive years, with -$2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 1798.2% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at $33000.0 (up 107.08% YoY), while the FY2025 annual figure was $2.0 million, up 16.14% from the prior year.
- Change in Receivables fell to -$2.1 million in Q1 2026 per TRAW's latest filing, from $1.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.8 million in Q4 2025 and bottomed at -$2.1 million in Q1 2026.
- Historically, Change in Receivables has averaged -$49555.6 across 5 years, with a median of -$12000.0 in 2023.
- Annual changes were most pronounced in 2025 — Change in Receivables surged 606.46% — and 2026, when it sank 1798.2%.
- Traws Pharma's Change in Receivables stood at -$1000.0 in 2022, then surged by 200.0% to $1000.0 in 2023, then slumped by 35700.0% to -$356000.0 in 2024, then soared by 606.46% to $1.8 million in 2025, then sank by 216.86% to -$2.1 million in 2026.
- Business Quant data shows TRAW's Change in Receivables at -$2.1 million in Q1 2026, $1.8 million in Q4 2025, and $668000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11 Mn |
| Mar 31, 2026 | -2.11 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 668,000.00 |
| Sep 30, 2025 | 668,000.00 |
| Jun 30, 2025 | -331,000.00 |
| Jun 30, 2025 | -331,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Dec 31, 2024 | -356,000.00 |
| Dec 31, 2024 | -356,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |